Asia Pacific Predictive Disease Analytics Market Size, Share and Case Studies

The global Asia Pacific predictive disease analytics market size reached approximately USD 0.54 billion in 2023 and is projected to grow to around USD 4.66 billion by 2033, achieving a CAGR of 24.05% from 2024 to 2033.

Significant growth in the Asia Pacific predictive disease analytics market stems from the rising demand for advanced healthcare solutions and the increasing burden of chronic diseases in the region. Predictive analytics utilizes historical data, machine learning, and statistical algorithms to identify potential health risks, improve patient outcomes, and enhance healthcare decision-making.

Asia Pacific Predictive Disease Analytics Market Report Highlights:

• The software and services segment captured the largest market share of 72% in 2023.
• This segment is expected to grow at a notable CAGR of 24.45% from 2024 to 2033.
• The on-premise deployment segment held the maximum market share of 67% in 2023.
• The cloud-based segment is projected to expand at the fastest CAGR of 25.13% over the forecast period.
• The healthcare payers end-use segment accounted for the largest market share of 42% in 2023.
• The healthcare providers segment is expected to register the fastest growth rate of 24.38% from 2024 to 2033.

Link to Download Report Free Sample: https://www.visionresearchreports.com/report/sample/40515

Predictive analytics and big data enhance operations in healthcare organizations and improve the accuracy of treatment and diagnosis in personalized medicine. Rising healthcare costs, reduced patient engagement and retention, and a lack of patient care are driving healthcare providers to adopt predictive disease analytics to tackle these challenges. According to the Philips Future Health Index (FHI) 2022, approximately 80% of healthcare leaders in the region believe that predictive disease analytics positively impacts staff and patient experience, health outcomes, health inequalities, and the cost of care.

Predictive analytics and big data enhance operations in healthcare organizations and improve the accuracy of treatment and diagnosis in personalized medicine. Rising healthcare costs, reduced patient engagement and retention, and a lack of patient care are driving healthcare providers to adopt predictive disease analytics to tackle these challenges. According to the Philips Future Health Index (FHI) 2022, approximately 80% of healthcare leaders in the region believe that predictive disease analytics positively impacts staff and patient experience, health outcomes, health inequalities, and the cost of care.

Case Studies in the Asia Pacific Predictive Disease Analytics Market

Case Study 1: Philips and AI-Driven Disease Prediction

Overview: Philips has integrated predictive analytics into its healthcare solutions, particularly focusing on AI-driven disease prediction. The company collaborates with the Department of Defense (DoD) to enhance disease prediction capabilities.

Implementation: In April 2023, the DoD received USD 10 million in funding to advance AI-driven disease prediction technologies. Philips developed algorithms that leverage data from wearable devices to predict infections up to 2-3 days before traditional diagnostic tests.

Results: This initiative demonstrated a significant reduction in response time for infectious disease management, improving patient outcomes and enabling timely interventions.

Case Study 2: Allscripts and Predictive Analytics in Chronic Care Management

Overview: Allscripts, a healthcare technology provider, deployed predictive analytics solutions across healthcare systems in the Asia Pacific region to enhance chronic disease management.

Implementation: By utilizing historical patient data and machine learning algorithms, Allscripts created predictive models that identify patients at risk of chronic conditions such as diabetes and heart disease. The system alerts healthcare providers to intervene early.

Results: Healthcare providers reported improved patient engagement and retention, leading to better management of chronic diseases. The predictive models led to a 20% reduction in hospital readmissions over a year.

Case Study 3: IBM Watson Health and Oncology Insights

Overview: IBM Watson Health has been active in the Asia Pacific region, applying predictive analytics to oncology to improve treatment outcomes for cancer patients.

Implementation: Watson Health utilized a vast dataset of clinical and genomic information to develop predictive models that help oncologists choose personalized treatment plans. These models analyze the effectiveness of various therapies based on individual patient profiles.

Results: Hospitals that implemented Watson’s predictive analytics reported a 30% improvement in treatment efficacy and a significant reduction in trial-and-error approaches, leading to faster and more effective cancer treatment decisions.

Case Study 4: NVIDIA and AI for Patient Monitoring

Overview: NVIDIA partnered with healthcare organizations in the Asia Pacific to leverage AI and predictive analytics for real-time patient monitoring.

Implementation: NVIDIA’s AI models analyzed data from wearable devices and electronic health records (EHR) to predict patient deterioration in real-time. The system provides alerts to healthcare staff, enabling timely intervention.

Results: The implementation led to a 25% decrease in emergency interventions needed for deteriorating patients, significantly enhancing patient safety and operational efficiency in healthcare settings.

Case Study 5: CureMetrix and Mammography Enhancement

Overview: CureMetrix uses AI-driven predictive analytics to improve mammography screening accuracy, focusing on breast cancer detection in Asia Pacific regions.

Implementation: The company’s software analyzes mammogram images using machine learning algorithms to predict the likelihood of breast cancer, assisting radiologists in identifying potential abnormalities.

Results: Healthcare facilities using CureMetrix reported a 40% increase in early breast cancer detection rates, enhancing patient outcomes and reducing the need for more aggressive treatments.

Key Benefits for Stakeholders

• This report provides a detailed quantitative analysis of the underground hydrogen storage market trends and forecast estimations from 2021 to 2033, which assists to identify the prevailing market opportunities.
• An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
• A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
• The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2033, in terms of value.
• An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
• Key market players within the underground hydrogen storage market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the underground hydrogen storage market.

Detailed TOC of Asia Pacific Predictive Disease Analytics Market Research Report, 2024-2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

Chapter 4. Market Variables and Scope?

Chapter 5. COVID 19 Impact on Asia Pacific Predictive Disease Analytics Market?

5.1. COVID-19 Landscape: Asia Pacific Predictive Disease Analytics Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Asia Pacific Predictive Disease Analytics Market, By Component

8.1. Asia Pacific Predictive Disease Analytics Market, by Component, 2024-2033

8.1.1 Hardware

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Software & Services

8.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Asia Pacific Predictive Disease Analytics Market, By Deployment

Chapter 10. Asia Pacific Predictive Disease Analytics Market, By End-use?

Chapter 11. Asia Pacific Predictive Disease Analytics Market, Regional Estimates and Trend Forecast

Asia Pacific

Chapter 12. Company Profiles

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Top Leaders in Asia Pacific Predictive Disease Analytics Market

• IBM Corp.
• Verisk Analytics, Inc.
• McKesson Corp.
• SAS Institute, Inc.
• Cotiviti, Inc.
• Optum, Inc.
• MedeAnalytics, Inc.
• Oracle

Buy this Premium Research Report@ https://www.visionresearchreports.com/report/checkout/40515

You can place an order or ask any questions, please feel free to contact [email protected]| +1 650-460-3308

About Us

Vision Research Reports is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys.